Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer
Clinical trial NCT04556539 · UNKNOWN
Trial details
- NCT number
- NCT04556539
- Sponsor
- Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2021-12-31
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.